普华永道：2020年医药市场展望报告 -（英文版）（32页）.pdf

1、Pharma 2020: Marketing the future Which path will you take? Pharmaceuticals and Life Sciences Table of contents Previous publications in this series include: Pharma 2020: The vision # Pharma 2020: The vision Which path will you take?* Pharmaceuticals *connectedthinking Pharma 2020: Virtual R and by

2、operating in a more connected world the industry, in collaboration with researchers, governments, healthcare payers and providers, can address the changing needs of society more effectively. Published in June 2007 this paper highlights a number of issues that will have a major bearing on the industr

3、y over the next 11 years. The publication outlines the changes we believe will best help pharmaceutical companies realise the potential the future holds to enhance the value they provide to shareholders and society alike. “Pharma 2020: Marketing the future” is the third in this series of papers on t

4、he future of the pharmaceutical industry published by PricewaterhouseCoopers. It discusses the key forces reshaping the pharmaceutical marketplace, including the growing power of healthcare payers, providers and patients, and the changes required to create a marketing and sales model that is fit for

5、 the 21st century. These changes will enable the industry to market and sell its products more cost-effectively, to create new opportunities and to generate greater customer loyalty across the healthcare spectrum. Pharma 2020: Marketing the future Table of contents Introduction 2 What will the healt

6、hcare landscape look like in 2020? 4 Recognising the interdependence of the pharmaceutical and healthcare value chains 8 Investing in the development of medicines the market wants to buy 10 Forming a web of alliances to offer supporting services 12 Developing a plan for marketing and selling special